Research ArticleOncology
Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer
Katharina Lückerath, Andreea D. Stuparu, Liu Wei, Woosuk Kim, Caius G. Radu, Christine E. Mona, Jeremie Calais, Matthew Rettig, Robert E. Reiter, Johannes Czernin, Roger Slavik, Ken Herrmann, Matthias Eiber and Wolfgang P. Fendler
Journal of Nuclear Medicine September 2018, 59 (9) 1392-1397; DOI: https://doi.org/10.2967/jnumed.118.207704
Katharina Lückerath
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Andreea D. Stuparu
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Liu Wei
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Woosuk Kim
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Caius G. Radu
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Christine E. Mona
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Jeremie Calais
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Matthew Rettig
2Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California
Robert E. Reiter
2Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California
Johannes Czernin
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Roger Slavik
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Ken Herrmann
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
3Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany
4German Cancer Consortium (DKTK), Heidelberg, Germany; and
Matthias Eiber
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
5Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Wolfgang P. Fendler
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 9
September 1, 2018
Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer
Katharina Lückerath, Andreea D. Stuparu, Liu Wei, Woosuk Kim, Caius G. Radu, Christine E. Mona, Jeremie Calais, Matthew Rettig, Robert E. Reiter, Johannes Czernin, Roger Slavik, Ken Herrmann, Matthias Eiber, Wolfgang P. Fendler
Journal of Nuclear Medicine Sep 2018, 59 (9) 1392-1397; DOI: 10.2967/jnumed.118.207704
Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer
Katharina Lückerath, Andreea D. Stuparu, Liu Wei, Woosuk Kim, Caius G. Radu, Christine E. Mona, Jeremie Calais, Matthew Rettig, Robert E. Reiter, Johannes Czernin, Roger Slavik, Ken Herrmann, Matthias Eiber, Wolfgang P. Fendler
Journal of Nuclear Medicine Sep 2018, 59 (9) 1392-1397; DOI: 10.2967/jnumed.118.207704
Jump to section
Related Articles
Cited By...
- 18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men
- PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study
- Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in Mice
- Preclinical Evaluation of 213Bi- and 225Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer
- The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
- Improving 68Ga-PSMA PET/MRI of the Prostate with Unrenormalized Absolute Scatter Correction
- Novel Structured Reporting Systems for Theranostic Radiotracers